Norgren J, Sindi S, Sandebring-Matton A, Kreholt I, Daniilidou M, Akenine U, Nordin K, Rosenborg S, Ngandu T, Kivipelto M
GLP-1 RAs offer promise for patients with HS and obesity and potentially for patients without obesity through immunological effects, the researchers concluded
Clin Transl Gastroenterol 2024;15(11):e00772
What happens after I get a prescription online
This means that the drug targets not one, but two unique incretin hormones produced by the human bodywhich has been shown to increase the efficacy of the drug compared to medications that target only GLP-1
Some of the most common are hypothyroidism, a distal vacuolar myopathy, pancreatic exocrine and endocrine insufficiency, male hypogonadism, and idiopathic intracranial hypertension